APA (7th ed.) Citation

A, C., B, P., A, D. M., Y, C., H, C., R, L., . . . MS, M. (2022). Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: A qualitative descriptive evaluation. Harm reduction journal, 19(1), 132. https://doi.org/10.1186/s12954-022-00718-1

Chicago Style (17th ed.) Citation

A, Corneli, et al. "Participant Perceptions on the Acceptability and Feasibility of a Telemedicine-based HIV PrEP and Buprenorphine/naloxone Program Embedded Within Syringe Services Programs: A Qualitative Descriptive Evaluation." Harm Reduction Journal 19, no. 1 (2022): 132. https://doi.org/10.1186/s12954-022-00718-1.

MLA (9th ed.) Citation

A, Corneli, et al. "Participant Perceptions on the Acceptability and Feasibility of a Telemedicine-based HIV PrEP and Buprenorphine/naloxone Program Embedded Within Syringe Services Programs: A Qualitative Descriptive Evaluation." Harm Reduction Journal, vol. 19, no. 1, 2022, p. 132, https://doi.org/10.1186/s12954-022-00718-1.